Hansa Biopharma AB (publ) (STO:HNSA)

Hansa Biopharma AB Revenue

Hansa Biopharma AB had revenue of 30.80M SEK in the quarter ending September 30, 2025, a decrease of -36.70%. This brings the company's revenue in the last twelve months to 178.61M, down -5.69% year-over-year. In the year 2024, Hansa Biopharma AB had annual revenue of 171.32M with 27.76% growth.

• Revenue (ttm): 178.61M
• Revenue Growth: -5.69%
• P/S Ratio: 19.03
• Revenue / Employee: 1.34M
• Employees: 135
• Market Cap: 3.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	171.32M	37.22M	27.76%
Dec 31, 2023	134.09M	-20.43M	-13.22%
Dec 31, 2022	154.53M	120.65M	356.12%
Dec 31, 2021	33.88M	27.78M	455.56%
Dec 31, 2020	6.10M	2.73M	81.27%